Archive for MHRA Updates
Class 2 Medicines Recall:Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL (21)A/19
Specific batches of products supplied by the Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. Source: MHRA 9th August 2021 Company...
Central Alert System- Tinzaparin Sodium Alert
Source: MHRA July 29, 2021 Unavailable From Mid October! MHRA has issued an alert via the Central Alert System for Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500...
Contractor Notice: SSP endorsement errors
Source: PSNC/ (NHSBSA) July 28, 2021 Following the announcement of the new Serious Shortage Protocols (SSP) endorsement which was introduced from 1 June 2021, PSNC has been working with NHS Business Services...
Medicine Supply Notification: Nexium® (esomeprazole) 10mg gastro-resistant granules sachets
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Nexium® (esomeprazole) 10mg gastro-resistant granules sachetsMSN/2021/038Tier 2 – medium impact Date of issue:...
Medicine Supply Notification: Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solutionMSN/2021/036Tier 2 –...
Medicine Supply Notification: Catapres® (clonidine) 100microgram tablets
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Catapres® (clonidine) 100microgram tabletsMSN/2021/037 Tier 2 – medium impact Date of issue: 21/07/2021...
Class 4 Medicines Defect Information, Amoxicillin
Class 4 Medicines Defect Information, Amoxicillin 500 mg/ 5 ml Powder for oral suspension, (PL 25298/0248), EL (21)A/18 Click here for the source
National Patient Safety Alert -inappropriate anticoagulation of patients with a mechanical heart valve
A National Patient Safety Alert has been issued on the risk of inappropriate anticoagulation of patients with a mechanical heart valve. National Patient Safety Alert – Inappropriate anticoagulation of patients...
Class 4 Medicines Defect Information, Sevredol 10 mg and 20mg tablets
Class 4 Medicines Defect Information, Sevredol 10 mg and 20mg tablets, (PL 16950/0063, PL 16950/0064), EL (21)A/17 Napp Pharmaceuticals Limited have noticed and an error in the PIL of specific...
Drug Safety Update- 7th July 2021
The Medicines and Healthcare products Regulatory Agency has published its latest Drug Safety Update for July 2021! Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger...
Class 4 Medicines Defect Information, Tetralysal 300mg Hard Capsules
Class 4 Medicines Defect Information, Tetralysal 300mg Hard Capsules, (PL 10590/0019), EL (21)A/16 Galderma UK identified an error regarding an older version of artwork being used and packed with specific...
Medicines recall: Morphine Syringe 50mg/50ml and Magnesium Sulphate 8mmol/20ml infusion
Company led medicines recall: Morphine Syringe 50mg/50ml (unlicensed medicine) and Magnesium Sulphate 8mmol/20ml infusion (unlicensed medicine) Source: MHRA Nova Laboratories Limited (MS 13581) is recalling specific batches of the impacted...